Migraine Nasal Spray Market Size & Share, by Drug Type (Ergotamine Dihydroergotamine, Ketorolac, Zolmitriptan); Distribution Channel (Hospital Pharmacies, Online Drug Store, Retail Pharmacies); Dosage (5 mg, 10 mg, 20 mg, 40 mg) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Migraine Nasal Spray Market size was valued at USD 536.33 million in 2024 and is likely to cross USD 1.26 billion by 2037, registering more than 6.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of migraine nasal spray is estimated at USD 567.33 million.

The market growth can be attributed to growing prevalence of migraine, backed by the increased stress, depression, sleep deprivation, and anxiety prevalent amongst the population. In fact, migraine is the third most common disease, and approximately 1 billion people suffer from migraine worldwide. Furthermore, scientists suggest that humans are facing extreme weather changes, which can aggravate their health, making diseases, such as, migraine a common phenomenon. According to the World Meteorological Organisation, [R1] the decade 2011-2020 was the warmest on record, and the year 2020 is among the three warmest years globally. The increasing adulteration in food, hormonal misbalance, and longer screen time are also major reasons behind the growing number of migraine patients. Scientists have also found that migraine is more pervasive in women owing to hormonal changes, as 8 out of 10 people with migraine are women. As the number of patients with migraine is increasing exponentially, people are seeking an efficient remedy to eradicate the excruciating pain, which is expected to expand the global migraine nasal spray market.